Websites Hosted in dnadns3e.gene.com Nameserver
The Nameserver dnadns3e.gene.com have a IP Address of 72.34.133.50 which is hosted on United States.
Genentech: Making Medicines that Matter
We use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions.
Cancer Research & Information from Genentech BioOncology | BioOncology
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Genentech Access Solutions
Learn how Genentech can help health care professionals and patients navigate the access and reimbursement process when a Genentech medicine is prescribed.
Cancer Information & Resources | Information About Cancer | Information About Cancer
Find helpful information about cancer including links and resources if you have been diagnosed with cancer, are being treated for cancer, or are living with cancer.
Advanced Skin Cancer Stories - Faces of Skin Cancer
Faces of Skin Cancer is a space for people affected by advanced skin cancer to share their stories.
Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
Discover Lucentis® (ranibizumab injection), a prescription medicine for the treatment of patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription...
Avastin® (bevacizumab) | Official Patient & Caregiver Website
Learn about Avastin (bevacizumab) solution for IV infusion, including benefits & risks, possible side effects, patient support, and options for financial help. Glioblastoma (GBM) Avastin is approved to treat glioblastoma (GBM) when taken alone in adult patients whose cancer has progressed after prior treatment...
Avastin® (bevacizumab) | Official Healthcare Professional (HCP) Website
For US HCPs: Access resources for Avastin (bevacizumab) solution for IV infusion, including efficacy data, safety profiles, and information on dosing and usage. Avastin is indicated for the treatment of metastatic renal cell carcinoma in combination with interferon alfa. Avastin is indicated for the treatment of...